JP2006516279A - 吸収促進剤としてスフィンゴミエリン及びリソスフィンゴミエリンを使用する方法 - Google Patents

吸収促進剤としてスフィンゴミエリン及びリソスフィンゴミエリンを使用する方法 Download PDF

Info

Publication number
JP2006516279A
JP2006516279A JP2006500734A JP2006500734A JP2006516279A JP 2006516279 A JP2006516279 A JP 2006516279A JP 2006500734 A JP2006500734 A JP 2006500734A JP 2006500734 A JP2006500734 A JP 2006500734A JP 2006516279 A JP2006516279 A JP 2006516279A
Authority
JP
Japan
Prior art keywords
lysosphingomyelin
sphingomyelin
food
uptake
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2006500734A
Other languages
English (en)
Japanese (ja)
Other versions
JP2006516279A5 (cg-RX-API-DMAC7.html
Inventor
ニューフェンフイゼン,ウィレム,フェルディナンド
Original Assignee
ネーデルランドセ オルガニサティエ フォール トエゲパストナトールヴェテンシャッペリク オンデルゾエク ティエヌオー
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ネーデルランドセ オルガニサティエ フォール トエゲパストナトールヴェテンシャッペリク オンデルゾエク ティエヌオー filed Critical ネーデルランドセ オルガニサティエ フォール トエゲパストナトールヴェテンシャッペリク オンデルゾエク ティエヌオー
Publication of JP2006516279A publication Critical patent/JP2006516279A/ja
Publication of JP2006516279A5 publication Critical patent/JP2006516279A5/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/14—Quaternary ammonium compounds, e.g. edrophonium, choline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A61K31/688—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols both hydroxy compounds having nitrogen atoms, e.g. sphingomyelins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Nutrition Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Mycology (AREA)
  • Rheumatology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
JP2006500734A 2003-01-20 2004-01-20 吸収促進剤としてスフィンゴミエリン及びリソスフィンゴミエリンを使用する方法 Pending JP2006516279A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
NL1022442A NL1022442C2 (nl) 2003-01-20 2003-01-20 Toepassing van lipide ter verbetring van de opname van nutrienten en (farmaceutisch) actieve stoffen.
PCT/NL2004/000047 WO2004064847A1 (en) 2003-01-20 2004-01-20 Use of sphingomyelin and lyso-sphingomyelin as absorption enhancers

Publications (2)

Publication Number Publication Date
JP2006516279A true JP2006516279A (ja) 2006-06-29
JP2006516279A5 JP2006516279A5 (cg-RX-API-DMAC7.html) 2007-03-01

Family

ID=32768714

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2006500734A Pending JP2006516279A (ja) 2003-01-20 2004-01-20 吸収促進剤としてスフィンゴミエリン及びリソスフィンゴミエリンを使用する方法

Country Status (5)

Country Link
US (1) US20060128666A1 (cg-RX-API-DMAC7.html)
EP (1) EP1585528A1 (cg-RX-API-DMAC7.html)
JP (1) JP2006516279A (cg-RX-API-DMAC7.html)
NL (1) NL1022442C2 (cg-RX-API-DMAC7.html)
WO (1) WO2004064847A1 (cg-RX-API-DMAC7.html)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008035604A1 (en) * 2006-09-22 2008-03-27 Asahi Breweries, Ltd. Composition for amelioration of brain function

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005281257A (ja) * 2004-03-30 2005-10-13 Snow Brand Milk Prod Co Ltd 美肌剤
US20100048928A1 (en) * 2005-09-22 2010-02-25 Snow Brand Milk Products Co., Ltd Medicine, Food and Drink or Feed Containing Sphingomyelin
ES2431142T3 (es) * 2006-04-07 2013-11-25 Megmilk Snow Brand Co., Ltd. Inhibidor de acumulación de grasa para el tratamiento de síndrome metabólico
EP2221057A4 (en) * 2007-11-19 2014-04-09 Megmilk Snow Brand Co Ltd MEANS FOR IMPROVING THE SENSES
JP2016013083A (ja) * 2014-07-01 2016-01-28 花王株式会社 麺つゆ

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH10257884A (ja) * 1997-03-18 1998-09-29 Takara Shuzo Co Ltd スフィンゴ脂質セラミドn−デアシラーゼ

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2492259A1 (fr) * 1980-10-21 1982-04-23 Idinvex Sa Formulation d'heparine
GB8712176D0 (en) * 1987-05-22 1987-06-24 Cosmas Damian Ltd Drug delivery system
US5374616A (en) * 1991-10-18 1994-12-20 Georgetown University Compositions containing sphingosylphosphorylcholine and the use thereof as a cellular growth factor
GB9301629D0 (en) * 1993-01-27 1993-03-17 Scotia Holdings Plc Formulations containing unsaturated fatty acids
US5478860A (en) * 1993-06-04 1995-12-26 Inex Pharmaceuticals Corp. Stable microemulsions for hydrophobic compound delivery
US5830853A (en) * 1994-06-23 1998-11-03 Astra Aktiebolag Systemic administration of a therapeutic preparation
AU7374396A (en) * 1995-09-29 1997-04-17 Georgetown University Use of sphingosylphosphorylcholine as a wound-healing agent
JP3581010B2 (ja) * 1998-03-18 2004-10-27 雪印乳業株式会社 脂質の消化吸収機能改善剤
EP1105141B1 (de) * 1998-08-06 2003-11-05 Wolfgang Stremmel Phosphatidylcholin als arzneimittel mit schleimhautschützender wirkung
JP3544493B2 (ja) * 1999-06-10 2004-07-21 雪印乳業株式会社 乳幼児用栄養組成物
KR20010026759A (ko) * 1999-09-08 2001-04-06 유병서 인지질이 첨가된 배합사료
US6761901B1 (en) * 2000-05-02 2004-07-13 Enzrel Inc. Liposome drug delivery

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH10257884A (ja) * 1997-03-18 1998-09-29 Takara Shuzo Co Ltd スフィンゴ脂質セラミドn−デアシラーゼ

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008035604A1 (en) * 2006-09-22 2008-03-27 Asahi Breweries, Ltd. Composition for amelioration of brain function
JP2008074785A (ja) * 2006-09-22 2008-04-03 Asahi Breweries Ltd 脳機能改善組成物

Also Published As

Publication number Publication date
EP1585528A1 (en) 2005-10-19
NL1022442C2 (nl) 2004-07-22
WO2004064847A1 (en) 2004-08-05
US20060128666A1 (en) 2006-06-15

Similar Documents

Publication Publication Date Title
US10052298B2 (en) Rapid-acting, blood-arginine-level-increasable oral preparation comprising citrulline and arginine
ES3003286T3 (en) Vitamin b2 and myo-inositol for treating and preventing gestational diabetes
CN102740865A (zh) 线粒体功能提高剂
US20140050805A1 (en) Composition, glucose metabolism-improving agent, and method for improving glucose metabolism
CN107105742A (zh) 含有白扁豆提取物作为有效成分的用于预防或改善非酒精性脂肪肝疾病的组合物
US20120309716A1 (en) Motor Function Improver
US20250228806A1 (en) Ampk activator, motor function improving agent, muscular endurance improving agent, and muscle atrophy preventing agent
NL1022443C2 (nl) Sphingolipiden voor verbetering van de samenstelling van de darmflora.
US20060128666A1 (en) Use of sphingomyelin and lyso-sphingomyelin as absorption enhancers
JP2011157328A (ja) ミトコンドリア機能向上剤
EP1618876A1 (en) Use of sphingolipids for prevention and treatment of atherosclerosis
EP4292601A1 (en) Composition for treating sarcopenia or osteoporosis through mechanism promoting formation of muscle fibers or inhibiting osteoclastogenesis, comprising cyclo-l-phenylalanyl-l-proline dipeptides
US20100197611A1 (en) Alternative agent with vitamin d-like activity and an improving agent for intestinal function
JP2007070343A (ja) 睡眠誘導剤、ストレス性不眠症改善剤
US20120094915A1 (en) Anti-mental fatigue drug
WO2025258679A1 (ja) 細胞内カルシウム濃度及びカルシウム依存性シグナル伝達経路の少なくとも一方を調節するための組成物
FR3148363A1 (fr) Composition pharmaceutique ou cosmétique favorisant la force des cheveux
KR20240178188A (ko) 찔레나무 추출물을 포함하는 비알코올성 지방간 질환의 개선, 예방 또는 치료용 조성물
JP2022090808A (ja) パーキンソン病様症状緩和剤
HK1126137A (en) Anti-fat-accumulation composition

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20070115

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20070115

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20100616

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20101122